These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Health regulatory communications of well-established safety-related pharmacogenomics associations in six developed countries: an evaluation of alignment. Tan-Koi WC; Lim ES; Teo YY Pharmacogenomics J; 2017 Mar; 17(2):121-127. PubMed ID: 26902540 [TBL] [Abstract][Full Text] [Related]
8. Pharmacogenomics: introduction and use in clinical practice. Saunders H; Harris D; Chirilă RM Rom J Intern Med; 2020 Jun; 58(2):69-74. PubMed ID: 32074077 [TBL] [Abstract][Full Text] [Related]
9. Falls: the adverse drug reaction of the elderly and the impact of pharmacogenetics. Just KS; Schneider KL; Schurig M; Stingl JC; Brockmöller J Pharmacogenomics; 2017 Aug; 18(13):1281-1297. PubMed ID: 28776468 [TBL] [Abstract][Full Text] [Related]
13. Pharmacogene Variation Consortium Gene Introduction: NUDT15. Yang JJ; Whirl-Carrillo M; Scott SA; Turner AJ; Schwab M; Tanaka Y; Suarez-Kurtz G; Schaeffeler E; Klein TE; Miller NA; Gaedigk A Clin Pharmacol Ther; 2019 May; 105(5):1091-1094. PubMed ID: 30515762 [No Abstract] [Full Text] [Related]
14. The challenges of implementing pharmacogenomic testing in the clinic. Moyer AM; Caraballo PJ Expert Rev Pharmacoecon Outcomes Res; 2017 Dec; 17(6):567-577. PubMed ID: 28949250 [TBL] [Abstract][Full Text] [Related]
15. Translation of pharmacogenomic drug labels into the clinic. Current problems. Ingelman-Sundberg M Pharmacol Res; 2020 Mar; 153():104620. PubMed ID: 31899313 [No Abstract] [Full Text] [Related]